CAMBRIDGE, Mass. – Dr. Hans-Christopher Diener has joined the clinical advisory board of Curelator Inc. to design and lead several multi-center global studies in headache disorders using the Curelator Headache mobile app. “We are delighted to have him join our team to design the first global real world clinical studies that employ a patient-centric digital platform to measure outcomes of different treatment strategies,” said Alec Mian, CEO and founder of Curelator, in a statement. Diener is currently a professor of neurology, chairman of the Department of Neurology and director of the Essen Headache Centre at the University of Duisburg-Essen in Germany. The studies will use the Curelator Headache app to measure the individual impact of treatment interventions for each patient participating in the studies.
You are here: / / Diener to lead headache disorder studies